The Lancet Gastroenterology & Hepatology
@LancetGastroHep
Followers
26K
Following
2K
Media
3K
Statuses
10K
The Lancet Gastroenterology & Hepatology is the world-leading #gastroenterology and #hepatology research journal. IF=38.6.
Joined February 2016
We are the world-leading journal dedicated to gastroenterology & hepatology research and review. While a partial measurement of our impact, we are pleased to share our 2024 Impact Factor is 38·6 & our Scopus CiteScore is 51·1. #GITwitter #LiverTwitter.
1
2
21
New Personal View - The psychobiological model of disorders of gut–brain interaction: introduction of a novel, integrated, and testable model. #GITwitter #MedTwitter @RomeGastroPsych
0
17
37
New @TheLancet - Antisense oligonucleotide DGAT-2 inhibitor, ION224, for metabolic dysfunction-associated steatohepatitis (ION224-CS2): results of a 51-week, multicentre, randomised, double-blind, placebo-controlled, ph 2 trial. #LiverTwitter #MedTwitter.
thelancet.com
This study provides the first clinical evidence that antisense-mediated inhibition of DGAT2 with ION224 could be a safe and efficacious strategy for the treatment of MASH. The observed histological...
0
2
4
New @TheLancetPH - Targeting alcohol use in high-risk population groups: a US microsimulation study of beverage-specific pricing policies. #alcohol #LiverTwitter #MedTwitter.
thelancet.com
Disproportionate increases in retail prices for the cheapest beverages, beer and spirits, might lead to a greater decline in consumption among high-risk groups. Pricing policies could thus be used as...
1
1
3
New Personal View - Overlooked determinants and unequal outcomes: rethinking metabolic dysfunction-associated steatotic liver disease beyond the biomedical model. #LiverTwitter #MedTwitter
1
13
25
RT @MarcBesselink: The #LEOPARD2 trial changed our nationwide practice dramatically: near ❌ stop laparoscopic #Whipple, rapid ✅ increase #….
0
21
0
FDA approves semaglutide for adults with metabolic-associated steatohepatitis with moderate-to-advanced fibrosis. #LiverTwitter #MedTwitter.
fda.gov
Action Will Provide New Therapy for Growing Public Health Issue
2
15
31
RT @ajeetsbhadoria: Published @WHO commissioned HBV Service Delivery and Care Cascade Outcome sys rev and meta-analysis in @LancetGastroHep….
0
5
0
New research - Service delivery models and care cascade outcomes for people living with chronic hepatitis B: a global systematic review and meta-analysis. #LiverTwitter #IDTwitter #MedTwitter
0
4
12
New Comment - Cultural competence in the delivery of nutrition and symptom care in irritable bowel syndrome. @nehagastrord @hmstaudacher . #GITwitter #IBS #MedTwitter
0
1
13
RT @TheLancet: Routine AI assistance may lead to loss of skills in health professionals who perform colonoscopies, study suggests in @Lance….
0
22
0
RT @business: Artificial intelligence, touted for its potential to transform medicine, led to some doctors losing skills after just a few m….
bloomberg.com
Artificial intelligence, touted for its potential to transform medicine, led to some doctors losing skills after just a few months in a new study.
0
26
0
RT @statnews: A new study suggests that, after having a specialized AI tool taken away, clinicians were less proficient at colonoscopies. h….
statnews.com
A new study suggests that, after having a specialized AI tool taken away, clinicians were less proficient at colonoscopies.
0
3
0
RT @EricTopol: Does A.I. support of physicians lead to their deskilling?.A new report of gastroenterologists doing colonoscopy for polyp de….
0
70
0
New research - Endoscopist deskilling risk after exposure to artificial intelligence in colonoscopy: a multicentre, observational study. #GITwitter #MedTwitter #AI.
thelancet.com
Continuous exposure to AI might reduce the ADR of standard non-AI assisted colonoscopy, suggesting a negative effect on endoscopist behaviour.
2
23
49
Our September 2025 issue is out now at . Content includes viral hepatitis, irritable bowel syndrome, diet, colorectal surgery, Crohn's disease, MASLD, primary biliary cholangitis, and more. #GITwitter #LiverTwitter #MedTwitter
0
10
39
New Comment - Addressing Africa's marginalisation in hepatocellular carcinoma clinical trials. @LewisRobertsMD #LiverTwitter #OncTwitter #MedTwitter.
thelancet.com
Hepatocellular carcinoma remains a substantial global public health concern, disproportionately affecting low-income and middle-income countries, particularly in Africa.1 Its burden in Africa is...
0
5
10
Efficacy and safety of ervogastat alone and in combination with clesacostat in patients with biopsy-confirmed metabolic dysfunction-associated steatohepatitis and F2–F3 fibrosis: results from a phase 2, randomised MIRNA study. #LiverTwitter #MedTwitter.
0
3
14
RT @WCRIFoundation: Have a look here: where the Lancet – @WCRIFoundation Committee on Research Integrity is announ….
0
13
0
RT @RFitzgerald_lab: Delighted to be featured on @TheLancet podcast sharing our findings from our recent BE surveillance paper published in….
0
7
0